Biopharma leaders are navigating through a period of evolving dynamics marked by AI-driven acceleration in advancing breakthroughs in therapeutics and commercial capabilities against a backdrop of compressed product lifecycles, mounting macroeconomic headwinds and disruptions in geopolitical order. Join BioNJ and industry leaders on October 30 to explore these converging forces, exchange proven resilience strategies and chart a course for sustaining innovation and growth in even the most unpredi
Thursday, October 30, 2025
Bridgewater, United States
From USD 695 - 895
Biopharma leaders are navigating through a period of evolving dynamics marked by AI-driven acceleration in advancing breakthroughs in therapeutics and commercial capabilities against a backdrop of compressed product lifecycles, mounting macroeconomic headwinds and disruptions in geopolitical order. Join BioNJ and industry leaders on October 30 to explore these converging forces, exchange proven resilience strategies and chart a course for sustaining innovation and growth in even the most unpredi
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox